Joel Jiang
Impact in
- Oncology top 1%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Colorectal Cancer Treatments and Studies
- Cutaneous Melanoma Detection and Management
-
- Diabetes Treatment and Management
Papers in
- Oncology 13
- Cancer Immunotherapy and Biomarkers 13
- CAR-T cell therapy research 9
-
- Melanoma and MAPK Pathways 4
- Muscle Physiology and Disorders 3
- Co-authors
- Jedd D. Wolchok (6 shared papers)James Larkin (6 shared papers)F. Stephen Hodi (10 shared papers)Dirk Schadendorf (4 shared papers)Christopher D. Lao (7 shared papers)Jeffrey S. Weber (3 shared papers)Ian M. Waxman (2 shared papers)Caroline Robert (2 shared papers)
- Journals
- Journal of Clinical Oncology (7 papers)The Lancet Oncology (2 papers)JAMA Oncology (2 papers)Diabetes Obesity and Metabolism (1 paper)Neurology (1 paper)
- Partner nations
- United StatesUnited KingdomSpain
In The Last Decade
Joel Jiang
23 papers receiving 3.6k citations
Joel Jiang's Hit Papers
Peers
Comparison fields: 5 of 96
- Oncology 2.1k
- Endocrinology, Diabetes and Metabolism 630
- Immunology 766
- Pulmonary and Respiratory Medicine 455
- Genetics 137
Countries citing papers authored by Joel Jiang
This map shows the geographic impact of Joel Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joel Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joel Jiang more than expected).
Fields of papers citing papers by Joel Jiang
This network shows the impact of papers produced by Joel Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joel Jiang. The network helps show where Joel Jiang may publish in the future.
Co-authors
The 25 scholars most cited alongside Joel Jiang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Nivolumab plus ipilimumab or nivolumab alone versus ipilimumab alone in advanced melanoma (CheckMate 067): 4-year outcomes of a multicentre, randomised, phase 3 trial Hit paper breakdown → | 2018 | 1049 |
| 2 | Safety Profile of Nivolumab Monotherapy: A Pooled Analysis of Patients With Advanced Melanoma Hit paper breakdown → | 2017 | 898 |
| 3 | 2013 | 282 | |
| 4 | 2016 | 265 | |
| 5 | 2014 | 229 | |
| 6 | 2014 | 193 | |
| 7 | 2015 | 176 | |
| 8 | 2016 | 144 | |
| 9 | 2017 | 96 | |
| 10 | 2008 | 89 | |
| 11 | 2020 | 77 | |
| 12 | 2016 | 65 | |
| 13 | 2017 | 30 | |
| 14 | 2015 | 28 | |
| 15 | 2014 | 19 | |
| 16 | 2022 | 16 | |
| 17 | 2016 | 14 | |
| 18 | 2018 | 11 | |
| 19 | 2017 | 6 | |
| 20 | 2025 | 2 |
About Joel Jiang
Joel Jiang is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Endocrinology, Diabetes and Metabolism and Immunology, having authored 25 papers that have together received 3.7k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (13 papers), CAR-T cell therapy research (9 papers), Melanoma and MAPK Pathways (4 papers), Muscle Physiology and Disorders (3 papers), Diabetes Treatment and Management (3 papers), Cancer Genomics and Diagnostics (2 papers), Immunotherapy and Immune Responses (2 papers) and Asthma and respiratory diseases (2 papers). The work is most often cited by research in Oncology (2.1k citations), Endocrinology, Diabetes and Metabolism (630 citations), Immunology (766 citations), Pulmonary and Respiratory Medicine (455 citations) and Genetics (137 citations). Joel Jiang has collaborated with scholars based in United States, United Kingdom and Spain. Frequent co-authors include Jedd D. Wolchok, James Larkin, F. Stephen Hodi, Dirk Schadendorf, Christopher D. Lao, Jeffrey S. Weber, Ian M. Waxman, Caroline Robert, Suzanne L. Topalian and Georgina V. Long. Their work appears in journals such as Journal of Clinical Oncology, The Lancet Oncology, JAMA Oncology, Diabetes Obesity and Metabolism and Neurology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.